AbCellera Biologics (ABCL) Interest & Investment Income (2022 - 2026)
AbCellera Biologics' Interest & Investment Income came in at $3.64 million for Q1 2026, down 34.0% from $5.52 million a year earlier and down 38.5% from the prior quarter.
Powered by 
Analysis
AbCellera Biologics (ABCL) Interest & Investment Income (2022 - 2026) Analysis & Trends
Over the trailing twelve months to Mar 31, 2026, AbCellera Biologics reported Interest & Investment Income of $23.92 million, down 28.8% year-over-year; for FY2025, it was $28.33 million, down 26.4% from FY2024.
- Interest & Investment Income carries a five-year compound annual growth rate of 149.5% (FY2020 to FY2025).
- Going back by year, Interest & Investment Income was $38.47 million in FY2024 (-8.9%), $42.25 million in FY2023 (+162.7%), $16.08 million in FY2022 (+382.9%) and $3.33 million in FY2021.
- The Q1 2026 figure represents the lowest quarterly Interest & Investment Income since Q2 2022.
- Year-over-year, Interest & Investment Income has declined for eight consecutive quarters, with an average decline of 25.7% over the last eight quarters.
- The fastest year-over-year change in Interest & Investment Income over five years came in Q2 2023 (growth of 662.3%), and the weakest in Q1 2025 (a decline of 46.9%).
- Business Quant data shows ABCL's Interest & Investment Income at $5.92 million (Q4 2025), $6.77 million (Q3 2025) and $7.59 million (Q2 2025) in the three quarters before Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 219.00 Mn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | - |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 80.00 Mn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 120.60 Mn |
| 10 | AbCellera Biologics | 3.89 Bn | 3.89 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 3.64 Mn |
| Dec 31, 2025 | 5.92 Mn |
| Sep 30, 2025 | 6.77 Mn |
| Jun 30, 2025 | 7.59 Mn |
| Mar 31, 2025 | 5.52 Mn |
| Dec 31, 2024 | 8.67 Mn |
| Sep 30, 2024 | 9.60 Mn |
| Jun 30, 2024 | 9.80 Mn |
| Mar 31, 2024 | 10.40 Mn |
| Dec 31, 2023 | 10.97 Mn |
| Sep 30, 2023 | 10.74 Mn |
| Jun 30, 2023 | 10.78 Mn |
| Mar 31, 2023 | 9.76 Mn |
| Dec 31, 2022 | 8.47 Mn |
| Sep 30, 2022 | 5.56 Mn |
| Jun 30, 2022 | 1.41 Mn |
| Mar 31, 2022 | 665,000.00 |
API Access
AbCellera Biologics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ABCL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "ABCL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ABCL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();